Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018

Palatin Technologies,Inc.
Posted on: 07 Sep 18
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018

PR Newswire

CRANBURY, N.J., Sept. 7, 2018

CRANBURY, N.J., Sept. 7, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2018 operating results on Thursday, September 13, 2018  before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 13, 2018 at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

Q4 and Fiscal Year End 2018 Financial Results Press Release 

9/13/2018 at 7:30 a.m. ET

Q4 and Fiscal Year End 2018 Conference Call-Live                     

9/13/2018 at 11:00 a.m. ET

US/Canada Dial-In Number:                                                          


International Dial-In Number:                                                        


Conference ID:                                                                              


Q4 and Fiscal Year End 2018 Conference Call-Replay                


US/Canada Dial-In Number:                                                          


International Dial-In Number:                                                        


Replay Passcode:                                                                         


Audio Webcast Live and Replay Access                  

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit

View original content with multimedia:

SOURCE Palatin Technologies, Inc.

PR Newswire

Last updated on: 07/09/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.